SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-010206
Filing Date
2024-03-18
Accepted
2024-03-18 08:36:09
Documents
15
Period of Report
2024-03-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38024
2 ex99-1.htm EX-99.1 65128
3 ex99-1_001.jpg GRAPHIC 3852
  Complete submission text file 0001493152-24-010206.txt   292408

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20240318.xsd EX-101.SCH 3045
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20240318_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20240318_pre.xml EX-101.PRE 22379
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3610
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 24757012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)